Premium
Improvement in Compensation for Chronic Poststroke Homonymous Hemianopsia After Initiation of a Selective Serotonin Reuptake Inhibitor: A Case Report
Author(s) -
Abramoff Benjamin A.,
Milton S. Byron,
Belagaje Samir R.
Publication year - 2017
Publication title -
pmandr
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.617
H-Index - 66
eISSN - 1934-1563
pISSN - 1934-1482
DOI - 10.1016/j.pmrj.2016.11.004
Subject(s) - serotonin reuptake inhibitor , hemianopsia , stroke (engine) , medicine , depression (economics) , physical medicine and rehabilitation , adverse effect , compensation (psychology) , anesthesia , psychology , psychiatry , antidepressant , ophthalmology , anxiety , visual field , mechanical engineering , macroeconomics , engineering , economics , psychoanalysis
Homonymous hemianopsia (HH) is a common adverse outcome after stroke. Spontaneous improvement more than 6 months poststroke is thought to be unlikely, and traditional visual rehabilitation techniques lack clear evidence of efficacy. The case presented is of a 22‐year‐old woman who demonstrated improved compensation of her stroke‐induced HH after the initiation of a selective serotonin reuptake inhibitor (SSRI). There is evidence supporting the use of SSRIs to improve poststroke cognitive impairment, motor impairment, and depression. This is the first case, however, demonstrating the potential novel use SSRIs to improve HH compensation after stroke, to our knowledge. Level of Evidence V